We are surgeons, engineers, nurses, and scientists
on a mission to advance surgical practice.

Mission

Advancing Surgical Complication Control & Prevention

Surgeons and their teams are leaders, problem solvers, and healers. They, along with patient safety experts, are continuously and tirelessly working to improve their complication prevention and control protocols. We share their belief that surgical complications should never be considered an inevitable outcome of high risk surgery. Our role is to support the hospital drive to zero by developing advanced technology that enhances hospital surgical complication control programs and bundles.

We believe that with technological innovation, greater awareness, and ongoing collaboration around best practices, we can help surgeons and hospitals significantly improve post-operative outcomes and patients' lives.

Science Source Ss2107236

The UnMet need

Critical Patient Safety Gaps

Surgical complications are a major source of illness following surgery, particularly acute in the 1MM+ annual high-risk abdominal surgeries where 15%+of patients develop a complication.1,2,3 Patients suffer, healthcare costs rise, and hospitals and surgeons are penalized. Wound contamination is the root cause of most surgical complications, yet after nearly a decade of national focus, surgical teams still struggle to gain control over this pervasive, invisible threat. Current surgical technologies have not evolved to adequately eliminate contamination, creating critical gaps that expose patients to risk. Hospital leaders are searching for the next generation of proven approaches to close these gaps, improve patient safety, and define a new standard of care.

Getty Images 688069451 Absurgery 5 Mg

Our Story

A Multi-Disciplinary Mind Meld

Our company was conceived at the Stanford Byers Center for Biodesign and accelerated at Stanford StartX Med and the Fogarty Institute for Innovation. Through extensive research and work with hospitals and patients, we realized that while new surgical techniques had transformed many areas of surgical practice, there had been little innovation in tools for peri-operative complication control.

We knew it would take the talents of a multi-disciplinary team to tackle surgical complications. Our team and board of advisors includes experts in surgery, surgical outcomes research, and medical technology development and commercialization. Their deep understanding of the surgical complication challenge plays a key role in the design and development of advanced technology that has immediate utility and longer-term benefits for hospital surgical complication control programs.

Jon Lisa About Page Mindmeld
Actionshot For Homepage

Zeroing in on Abdominal Surgery

Our first area of focus is abdominal surgery, with an emphasis on colorectal surgery where the risk, frequency and severity of surgical complications is high and the need is acute. Nearly 50 percent of abdominal incisions are contaminated during surgery.4 Our team collaborated closely with leading hospitals in abdominal surgery to create a technology platform and product that could be used in the full range of open and minimally invasive approaches utilized in their procedures.

Designed for Ease of Use & Control

Every aspect of our design and development is focused on putting more control into the expert hands of surgeons and nursing staff. Surgeons and surgical outcomes researchers in hospitals across the country provided critical feedback during our development process. These close collaborations are an integral part of how we work. The result is a first-in-class, advanced system that fits naturally and seamlessly into surgical workflow.

Leadership

Jonathan Coe

Jonathan Coe

Co-Founder, President & CEO

Jonathan Coe

Co-Founder, President & CEO

With more than a decade of experience in the medical device industry, Jon is both an inventor and a leader. Before co-founding Prescient Surgical as a Stanford Biodesign Innovation Fellow, Jon held a range of roles in engineering, marketing, and leadership in the surgical instrument divisions of Johnson & Johnson and Covidien. He is an inventor on 25 issued patents and successfully launched four major products in bariatric, general, and natural orifice surgery, and surgical oncology. He also started two interventional cardiology companies, Metavention and Gradient Therapeutics, and led the IP, technical, and pre-clinical efforts at Metavention through a successful Series B investment. Jon holds SB and MS degrees in Mechanical Engineering from MIT and Georgia Tech, respectively.

Jonathan Coe
Jeremy Koehler

Jeremy Koehler

Co-Founder

Jeremy Koehler

Co-Founder

As part of the Prescient Surgical founding team at Stanford Biodesign, Jeremy is an integral part of the core team that developed, engineered, and manufactured the company’s novel CleanCision system from the initial design phase to commercial launch. With a background in mechanical engineering, Jeremy has commercial medical device experience at Biomet Orthopedics (now Zimmer Biomet), as well as through various academic projects focused on treating a range of conditions in gastro-intestinal, cardiology, and musculoskeletal diseases. Jeremy received a BS and MS in Mechanical Engineering from Purdue University and University of Michigan, respectively, and was selected to participate in the Stanford University Biodesign Innovation Fellowship program.

Jeremy Koehler
Sasan Amirgholizadeh

Sasan Amirgholizadeh

Quality Manager

Sasan Amirgholizadeh

Quality Manager

Sasan came onboard with Prescient in November 2018 as the Quality Manager with over 20 years of experience in Quality, including Regulatory Affairs. Sasan’s career in Quality started during college, where he served as the Quality Specialist for two plasmapheresis centers. Since then, his Quality experience has expanded to include gastroenterology devices, biomedical telemetry devices, ophthalmic devices, and E-Beam and X-Ray. Sasan received his Bachelors of Arts degree from the University of North Texas.

Sasan Amirgholizadeh

Board of Directors

Brant Heise

Board Director
Managing Director, Summation Health Ventures

Eugene Chen

Executive Chair,
Managing Director, CWC HealthTech Advisors

Greg Bakan

Board Director
Chief Operating Officer, Fogarty Institute for Innovation

Advisory Board

Donald Fry MD

Executive Vice President for Clinical Outcomes, MPA Healthcare Solutions; Adjunct Professor of surgery at Northwestern University, Chicago, IL; Professor Emeritus, Department of Surgery at University of New Mexico School of Medicine, Albuquerque, NM. Previous leadership positions: Chair of the Department of Surgery at University of New Mexico; Chief of Surgery at University of New Mexico Hospital; President of the Surgical Infection Society of North America; President, Association of Virginia Surgeons

Insoo Suh MD

Co-Founder Prescient Surgical; Assistant Professor of Surgery, Division of General Surgery, Endocrine Surgery Section; Director of Research, Endocrine Surgical Oncology Lab, University of California, San Francisco

Mark Welton MD, MHCM, FACS, FASCRS

Co-Founder Prescient Surgical; Chief Medical Officer, Fairview Health Services, Minneapolis, MN; Professor of Surgery, University of Minnesota. Previous leadership positions: Harry A. Oberhelman Jr. Professor and Chief of Colon and Rectal Surgery at Stanford University School of Medicine, Palo Alto, CA; Chief of Staff, Stanford Hospital and Clinics; Medical Director of the Stanford Clinical Cancer Center.

Michael Goldfarb MD, FACS

Professor of Surgery, Drexel University College of Medicine, Philadelphia, PA. Previous leadership positions: Chair and Program Director, Department of Surgery, Monmouth Medical Center; Medical Director of Cramner Ambulatory Surgery Center, Monmouth Medical Center; Surgical coordinator, Jacqueline M. Wilentz Comprehensive Breast Center, Monmouth Medical Center, Monmouth, NJ; NJ Chapter President, American College of Surgeons; President, Society of Surgeons of New Jersey.

Motaz Qadan MD, PhD

Surgical Oncologist, Massachusetts General Hospital; Assistant Professor of Surgery, Harvard Medical School, Boston, MA. Previous leadership positions: Fellowship educational coordinator at Memorial Sloan-Kettering Cancer Center; Administrative Chief Resident, Stanford University School of Medicine, Palo Alto, CA.

Sue Barnes RN, CIC, FAPIC

Independent Clinical Consultant, Board certified in Infection Control and Prevention, Fellow of APIC (FAPIC). Previous leadership positions: National APIC Board of Directors; San Francisco APIC Chapter Board of Directors; Corporate Director Infection Prevention and Control Services, Kaiser Permanente.

Thomas Krummel MD, FACS/FAAP

Chair of Fogarty Institute for Innovation, Co-Director of Stanford Byers Center for Biodesign Program, Emile Holman professor at Stanford University School of Medicine, Palo Alto, CA. Previous leadership positions: Susan B. Ford Surgeon-in-Chief, Lucile Packard Children’s Hospital; Program Director of the General Surgery Residency Training Program, Stanford University, and former chair of the department of surgery, Stanford University School of Medicine.

Yuman Fong MD

Professor and chair of department of surgery at City of Hope, Sangiacomo Family chair of surgical oncology at City of Hope, Duarte, CA. Previous leadership positions: Murray F. Brennan chair of surgery, Memorial Sloan-Kettering Cancer Center, New York, NY; Vice Chair of Technology Development, Memorial Sloan-Kettering Cancer Center; Professor of Surgery, Weill Cornell Medical College, New York, NY.

Collaborations

Baylor University Medical Center

Dallas, TX

Intermountain McKay-Dee Hospital

Ogden, UT

Stony Brook Medicine

Stony Brook, NY

Baylor Scott & White

Temple, Texas

Washington University School of Medicine

St. Louis, Missouri

Lahey Hospital and Medical Center

Burlington, Massachusetts

Ochsner Clinic

New Orleans, Louisiana

Contact Us

Ready to get started?

Get in touch

References

1 Tanner J, Khan D, Aplin C, Ball J, Thomas M, Bankart J. Post-discharge surveillance to identify colorectal surgical site infection rates and related costs. J Hosp Infect. 2009;72(3):243-250.

2 Watanabe A, Kohnoe S, Shimabukuro R, et al. Risk factors associated with surgical site infection in upper and lower gastrointestinal surgery. Surg Today. 2008;38(5):404-412.

3 Wick EC, Vogel JD, Church JM, Remzi F, Fazio VW. Surgical site infections in a "high outlier" institution: are colorectal surgeons to blame? Dis Colon Rectum. 2009;52(3):374-379.

4 Fa-Si-Oen PR, Kroeze F, Verhoef LH, Verwaest C, Roumen RM. Bacteriology of abdominal wounds in elective open colon surgery: a prospective study of 100 surgical wounds. Clin Microbiol Infect. 2005;11(2):155-157.